Jiangsu Jibeier Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of March 2026: 2.98%

Jiangsu Jibeier Pharmaceutical Co Ltd asset resilience ratio. Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has an Asset Resilience Ratio of 2.98% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jiangsu Jibeier Pharmaceutical Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥81.09 Million
≈ $11.87 Million USD Cash + Short-term Investments

Total Assets

CN¥2.72 Billion
≈ $398.43 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Jiangsu Jibeier Pharmaceutical Co Ltd (2021–2025)

Asset resilience ratio of Jiangsu Jibeier Pharmaceutical Co Ltd from 2021 to 2025. This chart shows how Jiangsu Jibeier Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 688566 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Jiangsu Jibeier Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Jiangsu Jibeier Pharmaceutical Co Ltd (688566) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥81.09 Million 2.98%
Total Liquid Assets CN¥81.09 Million 2.98%

Asset Resilience Insights

  • Limited Liquidity: Jiangsu Jibeier Pharmaceutical Co Ltd maintains only 2.98% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Jiangsu Jibeier Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangsu Jibeier Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Ajanta Pharma Limited
NSE:AJANTPHARM
Drug Manufacturers - Specialty & Generic 14.99%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
Drug Manufacturers - Specialty & Generic 26.45%
Porton Fine Chemicals Ltd
SHE:300363
Drug Manufacturers - Specialty & Generic 6.85%
Jubilant Pharmova Limited
NSE:JUBLPHARMA
Drug Manufacturers - Specialty & Generic 1.26%

Jiangsu Jibeier Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2021–2025)

Jiangsu Jibeier Pharmaceutical Co Ltd asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Jiangsu Jibeier Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.36% CN¥37.03 Million
≈ $5.42 Million
CN¥2.72 Billion
≈ $397.60 Million
-0.85pp
2024-12-31 2.22% CN¥56.00 Million
≈ $8.19 Million
CN¥2.53 Billion
≈ $369.86 Million
+0.63pp
2023-12-31 1.58% CN¥35.00 Million
≈ $5.12 Million
CN¥2.21 Billion
≈ $323.34 Million
-3.00pp
2022-12-31 4.58% CN¥90.00 Million
≈ $13.17 Million
CN¥1.96 Billion
≈ $287.48 Million
-6.42pp
2021-12-31 11.00% CN¥200.00 Million
≈ $29.27 Million
CN¥1.82 Billion
≈ $266.13 Million
--
pp = percentage points

About Jiangsu Jibeier Pharmaceutical Co Ltd

SHG:688566 China Drug Manufacturers - Specialty & Generic
Market Cap
$757.76 Million
CN¥5.18 Billion CNY
Market Cap Rank
#9817 Global
#2533 in China
Share Price
CN¥25.75
Change (1 day)
-3.59%
52-Week Range
CN¥23.10 - CN¥32.66
All Time High
CN¥51.60
About

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company's products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing… Read more